RELATION OF PULMONARY LYMPHANGIOLEIOMYOMATOSIS TO USE OF THE ORAL-CONTRACEPTIVE PILL AND FERTILITY IN THE UK - A NATIONAL CASE-CONTROL STUDY

被引:38
|
作者
WAHEDNA, I
COOPER, S
WILLIAMS, J
PATERSON, IC
BRITTON, JR
TATTERSFIELD, AE
机构
[1] CITY HOSP NOTTINGHAM,DIV RESP MED,NOTTINGHAM NG5 1PB,ENGLAND
[2] CTY HOSP,LINCOLN LN2 5QY,ENGLAND
关键词
D O I
10.1136/thx.49.9.910
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background - Pulmonary lymphangioleiomyomatosis is a rare progressive disease of unknown aetiology affecting premenopausal women. Since the oral contraceptive pill has been implicated in its pathogenesis, a case control study was carried out to determine whether women with the disease were more likely to have taken the oral contraceptive pill, and whether the disease was associated with other conditions related to sex hormones including pregnancy, parity, and fibroids. Methods - All chest physicians in the UK were asked for details of all live patients with pulmonary lymphangioleiomyomatosis; the patient's family doctor was then asked for four age and sex matched control subjects from their patient register. Details of lifetime use of the oral contraceptive pill, pregnancy, parity, history of fibroids, and smoking were obtained from cases and controls. Relative odds of exposure to potential risk factors were estimated by conditional logistic regression. Results - Medical details were obtained from all 23 cases of lymphangioleiomyomatosis identified; questionnaires were completed by 21 cases (one by proxy) and by 46 matched controls of mean (SD) age 43 (10) and 44 (11) years, respectively. The patients had a mean age of 34 (9) years at onset of symptoms and a median (range) time of 2 (0-29) years from onset of symptoms to diagnosis. Compared with control subjects, cases did not differ in the use of the oral contraceptive pill (odds ratio (OR) 0.39, 95% CI 0.09 to 1.68), diagnosis of fibroids (OR 3.12; 95% CI 0.52 to 18.7), age of menarche, menstrual history, or lifetime smoking. They were, however, less likely to have been pregnant (OR 0.14, 95% CI 0.03 to 0.71) or to have had children (OR 0.13, 95% CI 0.03 to 0.67). More pregnancies had ended in spontaneous abortion (28% v 8%) but the proportion of women undergoing spontaneous abortion was similar in cases and controls (OR 2.13, 95% CI 0.47 to 9.3). Conclusions - This study does not support the hypothesis that use of the oral contraceptive pill is causally associated with the development of pulmonary lymphangioleiomyomatosis. Sex hormones may be involved, however, since patients were less likely to have been pregnant or to have had children, and tended to have had more spontaneous abortions and an increased incidence of fibroids.
引用
收藏
页码:910 / 914
页数:5
相关论文
共 50 条
  • [41] A CASE-CONTROL STUDY OF BREAST-CANCER IN RELATION TO THE USE OF STEROID-CONTRACEPTIVE AGENTS
    ELLERY, C
    MACLENNAN, R
    BERRY, G
    SHEARMAN, RP
    MEDICAL JOURNAL OF AUSTRALIA, 1986, 144 (04) : 173 - 176
  • [42] RE: "A CASE-CONTROL STUDY OF ORAL CONTRACEPTIVE USE AND INCIDENT BREAST CANCER" - THE AUTHORS REPLY
    Rosenberg, Lynn
    Zhang, Yuqing
    Coogan, Patricia F.
    Strom, Brian L.
    Palmer, Julie R.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2009, 170 (06) : 803 - 804
  • [43] A pooled analysis of 10 case-control studies of melanoma and oral contraceptive use
    Karagas, MR
    Stukel, TA
    Dykes, J
    Miglionico, J
    Greene, MA
    Carey, M
    Armstrong, B
    Elwood, JM
    Gallagher, RP
    Green, A
    Holly, EA
    Kirkpatrick, CS
    Mack, T
    Osterlind, A
    Rosso, S
    Swerdlow, AJ
    BRITISH JOURNAL OF CANCER, 2002, 86 (07) : 1085 - 1092
  • [44] Oral contraceptive use, hormone replacement therapy and rectal cancer: A population based case-control study
    Long, Millie
    Martin, Christopher
    Sandler, Robert
    GASTROENTEROLOGY, 2008, 134 (04) : A60 - A60
  • [45] ORAL-CONTRACEPTIVE AGENTS AND BREAST-CANCER - A POPULATION-BASED CASE CONTROL STUDY
    ROHAN, TE
    MCMICHAEL, AJ
    MEDICAL JOURNAL OF AUSTRALIA, 1988, 149 (10) : 520 - &
  • [46] RECENT TRENDS IN INCIDENCE OF AND MORTALITY FROM BREAST, OVARIAN AND ENDOMETRIAL CANCERS IN ENGLAND AND WALES AND THEIR RELATION TO CHANGING FERTILITY AND ORAL-CONTRACEPTIVE USE
    SILVA, ID
    SWERDLOW, AJ
    BRITISH JOURNAL OF CANCER, 1995, 72 (02) : 485 - 492
  • [47] EPIDEMIOLOGIC-STUDY OF BREAST-CANCER AND BENIGN BREAST NEOPLASIAS IN RELATION TO THE ORAL-CONTRACEPTIVE AND ESTROGEN USE
    RAVNIHAR, B
    SEIGEL, DG
    LINDTNER, J
    EUROPEAN JOURNAL OF CANCER, 1979, 15 (04) : 395 - 405
  • [48] Oral contraceptive and IUD use and endometrial cancer: A population-based case-control study in Shanghai, China
    Tao, Meng Hua
    Xu, Wang Hong
    Zheng, Wei
    Zhang, Zuo-Feng
    Gao, Yu-Tang
    Ruan, Zhi Xian
    Cheng, Jia Rong
    Gao, Jing
    Xiang, Yong Bing
    Shu, Xiao Ou
    INTERNATIONAL JOURNAL OF CANCER, 2006, 119 (09) : 2142 - 2147
  • [49] ORAL-CONTRACEPTIVE AGENTS AND THE RISK OF MAMMARY-CARCINOMA IN THE GDR - RESULTS OF A CASE-CONTROL-STUDY
    EBELING, K
    THOMAS, D
    NISCHAN, P
    RAY, R
    KUNDE, D
    JOHANNSMEYER, B
    GLODDE, L
    KRUGER, E
    ZEITSCHRIFT FUR KLINISCHE MEDIZIN-ZKM, 1990, 45 (13): : 1113 - 1120
  • [50] Use of Oral Glucocorticoids and the Risk of Pulmonary Embolism A Population-Based Case-Control Study
    Stuijver, Danka J. E.
    Majoor, Christof J.
    van Zaane, Bregje
    Souverein, Patrick C.
    de Boer, Anthonius
    Dekkers, Olaf M.
    Bueller, Harry R.
    Gerdes, Victor E. A.
    CHEST, 2013, 143 (05) : 1337 - 1342